Skip to main content
TipRanks
Go Ultimate75% OFF

Zimmer Biomet Holdings (ZBH) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

ZBH Analyst Ratings

Moderate Buy
17Ratings
5Buy12Hold0Sell
Based on 17 analysts giving stock ratings to Zimmer Biomet Holdings in the past 3 months

ZBH Stock 12 Month Forecast

CHF99.29â–²(15.45% Upside)
Based on 17 Wall Street analysts offering 12 month price targets for Zimmer Biomet Holdings in the last 3 months. The average price target is CHF 99.29 with a high forecast of CHF 118.05 and a low forecast of CHF 85.16. The average price target represents a 15.45% change from the last price of CHF 86.00.
Highest Price TargetCHF118.05Average Price TargetCHF99.29Lowest Price TargetCHF85.16

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for CH:ZBH
Price TargetArticle
Leerink PartnersCHF92.75→CHF94.44hold9.81%UpsideAssigned11/19/26
Wells FargoCHF95.28→CHF103.71buy20.60%UpsideUpgraded11/17/26
Stifel NicolausCHF105.40→CHF118.05buy37.26%UpsideReiterated11/16/26
BMO CapitalCHF86.01→CHF85.16hold-0.97%DownsideReiterated11/16/26
Bank of America SecuritiesCHF92.75→CHF101.18hold17.66%UpsideReiterated11/15/26
BarclaysCHF84.32→CHF96.97hold12.75%UpsideReiterated11/09/26
Piper SandlerCHF92.75hold7.85%UpsideReiterated11/09/26
BernsteinCHF78.42→CHF90.22hold4.91%UpsideAssigned11/05/26
Robert W. BairdCHF87.69→CHF96.12hold11.77%UpsideReiterated11/05/26
Canaccord GenuityCHF84.32→CHF93.59hold8.83%UpsideReiterated11/05/26
UBSCHF101.18→CHF109.62buy27.46%UpsideAssigned11/05/26
J.P. MorganCHF98.65→CHF101.18hold17.66%UpsideReiterated11/05/26
Truist FinancialCHF89.38→CHF96.12hold11.77%UpsideReiterated11/05/26
RBC CapitalCHF92.75→CHF105.40buy22.56%UpsideReiterated11/04/26
CitiCHF83.48→CHF98.65hold14.71%UpsideAssigned11/04/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PALIPalisade Bio
RZLTRezolute
MDWDMediwound
OVIDOvid Therapeutics
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Zimmer Biomet Holdings

3 Months
David Toung
David ToungArgus Research
Success Rate6/11 ratings generated profit
55%
Average Return
-0.82%

Copying David Toung's trades and holding each position for 3 Months would result in 54.55% of your transactions generating a profit, with an average return of -0.82% per trade.

1 Year
Rick Wise
Rick WiseStifel Nicolaus
Success Rate13/28 ratings generated profit
46%
Average Return
+1.67%

Copying Rick Wise's trades and holding each position for 1 Year would result in 46.43% of your transactions generating a profit, with an average return of +1.67% per trade.

2 Years
Vijay Kumar
Vijay KumarEvercore ISI
Success Rate6/13 ratings generated profit
46%
Average Return
+0.25%

Copying Vijay Kumar's trades and holding each position for 2 Years would result in 46.15% of your transactions generating a profit, with an average return of +0.25% per trade.

ZBH Analyst Recommendation Trends

010203040Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for ZBH
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy510977
Hold1022222223
Sell00000
Strong Sell00000
total1532312930

In the current month, ZBH has received 7 Buy Ratings, 23 Hold Ratings, and 0 Sell Ratings. ZBH average Analyst price target in the past 3 months is 99.29.

ZBH Financial Forecast

CHF0CHF0.75CHF1.5CHF2.25CHF3Q1 2026Q3 2026Q4 2026
HighCHF2.13
ConsensusCHF2.10
LowCHF2.06

ZBH Earnings Forecast

Next quarter’s earnings estimate for ZBH is CHF 2.10 with a range of CHF 2.06 to CHF 2.13. The previous quarter’s EPS was CHF 1.60. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

CHF1.7BCHF1.8BCHF1.8BCHF1.9BCHF1.9BQ1 2026Q3 2026Q4 2026
HighCHF1.93B
ConsensusCHF1.92B
LowCHF1.91B

ZBH Sales Forecast

Next quarter’s sales forecast for ZBH is CHF 1.92B with a range of CHF 1.91B to CHF 1.93B. The previous quarter’s sales results were CHF 1.73B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

ZBH Stock Forecast FAQ

What is CH:ZBH’s average 12-month price target, according to analysts?
Based on analyst ratings, Zimmer Biomet Holdings’s 12-month average price target is CHF99.29.
What is CH:ZBH’s upside potential, based on the analysts’ average price target?
Zimmer Biomet Holdings has 15.45% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Zimmer Biomet Holdings a Buy, Sell or Hold?
Zimmer Biomet Holdings has a consensus rating of Moderate Buy, which is based on 5 buy ratings, 12 hold ratings and 0 sell ratings.
What is Zimmer Biomet Holdings’s share price target?
The average share price target for Zimmer Biomet Holdings is CHF99.29. This is based on 17 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF118.05, and the lowest forecast is CHF85.16. The average share price target represents a 15.45% increase from the current price of CHF86.
What do analysts say about Zimmer Biomet Holdings?
Zimmer Biomet Holdings’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 17 Wall Street analysts.
How can I buy shares of Zimmer Biomet Holdings?
To buy shares of CH:ZBH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.